Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants are eligible to be included in the study only if all the following criteria apply:
You may not be if
Able to provide written informed consent (IC) prior to any study procedures and willing and able to comply with study procedures
In the opinion of the investigator, the participant demonstrated adequate compliance with the study procedures in Study RLM-MD-01 or RLM-MD-02
Participants are excluded from the study if any of the following criteria apply:
Participant is not willing or able to abide by the restrictions regarding concomitant medicine use
Participant is planning to receive an investigational drug (other than study treatment) or investigational device at any time during Study RLM-MD-03
Participant has an unresolved adverse event (AE) or a clinically significant finding on physical examination, clinical laboratory test, or 12-lead electrocardiogram (ECG) that, in the investigator's opinion, would limit the participant's ability to participate in or complete the study
Any other reason that, in the investigator's opinion, would confound proper interpretation of the study or expose a participant to unacceptable risk, including renal, hepatic or cardiopulmonary disease
Clareo Health | A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
